Stockysis — AI-Powered Stock News & Sentiment Analysis

HC Wainwright & Co. Maintains Buy on Olema Pharmaceuticals, Lowers Price Target to $38

Benzinga Newsdesk www.benzinga.com Neutral 55.1%

Neg 0% Neu 55.1% Pos 0%

HC Wainwright & Co. analyst Emily Bodnar maintains Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy and lowers the price target from $45 to $38.

Comments

No comments yet. Be the first!